Resubmission of 2013 comment documenting ecigarette cessation claims in their marketing

June 3, 2014
 
Docket No. FDA-2014-N-0189
 
I am resubmitting the following public comment, submitted to an earlier docket:
 
Grana, R., Ling, P.M., Barnes, R.L., Lempert, L., Glantz, S.A.  (2013). Comment submitted regarding Feed and Drug Administration actions related to Nicotine Replacement Therapies and smoking-cessation products; report to Congress on innovative products and treatments for tobacco dependence; public hearing; extension of comment period. tracking # 1jx-835b-n9ph.
 
This comment is referenced in the following comment, which was just submitted to the current docket: FDA Should Prohibit E-cigarette Marketing that Promotes False Health Claims, tracking number 1jy-8cgs-l1sq
 
Stanton A. Glantz, PhD
Professor of Medicine
 
This is comment number 1jy-8cgt-ek20.  (This file has all the advertising examples in it.)